{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:49:59Z","timestamp":1790419799802,"version":"4.1.0"},"reference-count":201,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01290","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T01:15:29Z","timestamp":1560215729000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":90,"title":["Dermatitis Herpetiformis: Novel Perspectives"],"prefix":"10.3389","volume":"10","author":[{"given":"Emiliano","family":"Antiga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Maglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Quintarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Verdelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Bonciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Bonciolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Caproni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/jama.250.2.212","article-title":"Landmark article, Aug 30, 1884: Dermatitis herpetiformis","volume":"250","author":"Duhring","year":"1983","journal-title":"JAMA"},{"key":"B2","first-page":"34","article-title":"Effect of sulfonamides and sulfones on Duhring's disease","volume":"2","author":"Esteves","year":"1952","journal-title":"Clin Lat"},{"key":"B3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2133.1969.tb16024.x","article-title":"Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis","volume":"81","author":"van der Meer","year":"1969","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/S0140-6736(66)91692-8","article-title":"Small-bowel changes in dermatitis herpetiformis","volume":"2","author":"Marks","year":"1966","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1172\/JCI107123","article-title":"HL-A8: a genetic link between dermatitis herpetiformis and gluten-sensitive enteropathy","volume":"51","author":"Katz","year":"1972","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0140-6736(73)91539-0","article-title":"Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal","volume":"1","author":"Fry","year":"1973","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1468-3083.2009.03188.x","article-title":"Guidelines for the diagnosis and treatment of dermatitis herpetiformis","volume":"23","author":"Caproni","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2133.2001.03981.x","article-title":"Tissue transglutaminase antibody assessment in dermatitis herpetiformis","volume":"144","author":"Caproni","year":"2001","journal-title":"Br J Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"Sardy","year":"2002","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2340\/00015555-3001","article-title":"Granular IgA deposits in the skin of patients with coeliac disease: is it always dermatitis herpetiformis?","volume":"99","author":"Bonciolini","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/jama.2017.9730","article-title":"Celiac disease and non-celiac gluten sensitivity: a review","volume":"318","author":"Leonard","year":"2017","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2133.2008.08629.x","article-title":"Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis","volume":"159","author":"Hull","year":"2008","journal-title":"Br J Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/archdermatol.2010.336","article-title":"Remission in dermatitis herpetiformis: a cohort study","volume":"147","author":"Paek","year":"2011","journal-title":"Arch Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/08830185.2018.1533008","article-title":"An update on the cutaneous manifestations of coeliac disease and non-coeliac gluten sensitivity","volume":"37","author":"Graziano","year":"2018","journal-title":"Int Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.jaad.2010.09.777","article-title":"Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation","volume":"64","author":"Bolotin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2133.2011.10385.x","article-title":"Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland","volume":"165","author":"Salmi","year":"2011","journal-title":"Br J Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1468-3083.2011.04204.x","article-title":"Dermatitis herpetiformis in China: a report of 22 cases","volume":"26","author":"Zhang","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/bjd.13965","article-title":"Unique characteristics in Japanese dermatitis herpetiformis","volume":"174","author":"Ohata","year":"2016","journal-title":"Br J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/ajg.2014.55","article-title":"Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study","volume":"109","author":"West","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1001\/archderm.1992.04530010046006","article-title":"The incidence and prevalence of dermatitis herpetiformis in Utah","volume":"128","author":"Smith","year":"1992","journal-title":"Arch Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/00365520903030795","article-title":"Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults","volume":"44","author":"Virta","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1053\/gast.2002.36585","article-title":"Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis","volume":"123","author":"Askling","year":"2002","journal-title":"Gastroenterology"},{"key":"B23","first-page":"163","article-title":"Clinical and immunopathological features of 159 patients with dermatitis herpetiformis: an Italian experience","volume":"148","author":"Antiga","year":"2013","journal-title":"G Ital Dermatol Venereol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/07853890.2016.1222450","article-title":"Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease","volume":"49","author":"Collin","year":"2017","journal-title":"Ann Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2340\/00015555-2818","article-title":"Diagnostic delay in dermatitis herpetiformis in a high-prevalence area","volume":"98","author":"Mansikka","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.coph.2018.12.007","article-title":"Pharmacological advances in pemphigoid","volume":"46","author":"Maglie","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jid.2018.10.010","article-title":"Dermatitis herpetiformis and celiac disease increase the risk of bullous pemphigoid","volume":"139","author":"Varpuluoma","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1365-2036.2012.04998.x","article-title":"The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study","volume":"35","author":"Grainge","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2133.1993.tb03516.x","article-title":"Mortality and cancer incidence in patients with dermatitis herpetiformis: a cohort study","volume":"129","author":"Swerdlow","year":"1993","journal-title":"Br J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.dld.2006.03.002","article-title":"Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study","volume":"38","author":"Viljamaa","year":"2006","journal-title":"Dig Liver Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/j.1365-2036.2008.03660.x","article-title":"No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study","volume":"27","author":"Lewis","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1365-2133.2012.11105.x","article-title":"Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients","volume":"167","author":"Hervonen","year":"2012","journal-title":"Br J Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/bjd.12319","article-title":"Is dermatitis herpetiformis a proxy of prosperity?","volume":"169","author":"Ali","year":"2013","journal-title":"Br J Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/014107689709000504","article-title":"Risk factors for ischaemic heart disease in patients with dermatitis herpetiformis","volume":"90","author":"Lear","year":"1997","journal-title":"J R Soc Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ijc.2910230504","article-title":"Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects","volume":"23","author":"Ferson","year":"1979","journal-title":"Int J Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/gut.31.4.378","article-title":"Mucosal immunodeficiency in smokers, and in patients with epithelial head and neck tumours","volume":"31","author":"Barton","year":"1990","journal-title":"Gut"},{"key":"B37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00128071-200304010-00002","article-title":"Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists","volume":"4","author":"Collin","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1053\/j.gastro.2005.02.026","article-title":"Skin manifestations of celiac disease","volume":"128","author":"Zone","year":"2005","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"E602","DOI":"10.3390\/nu10050602","article-title":"Dermatitis herpetiformis: a common extraintestinal manifestation of coeliac disease","volume":"10","author":"Reunala","year":"2018","journal-title":"Nutrients"},{"key":"B40","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1046\/j.1365-4362.2003.01804.x","article-title":"Dermatitis herpetiformis","volume":"42","author":"Nicolas","year":"2003","journal-title":"Int J Dermatol"},{"key":"B41","first-page":"E559","article-title":"Oral manifestations of celiac disease","volume":"13","author":"da Silva","year":"2008","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/j.1365-2036.2007.03535.x","article-title":"Oral pathology in untreated coeliac [corrected] disease","volume":"26","author":"Campisi","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"952753","DOI":"10.1155\/2012\/952753","article-title":"Celiac disease and dermatologic manifestations: many skin clue to unfold gluten-sensitive enteropathy","volume":"2012","author":"Caproni","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"B44","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1046\/j.0909-8836.1998.eos106501.x","article-title":"Oral mucosal changes in coeliac patients on a gluten-free diet","volume":"106","author":"Lahteenoja","year":"1998","journal-title":"Eur J Oral Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S0738-081X(00)00184-X","article-title":"Dermatitis herpetiformis","volume":"19","author":"Reunala","year":"2001","journal-title":"Clin Dermatol"},{"key":"B46","first-page":"159","article-title":"Is dermatitis herpetiformis changing?","volume":"148","author":"Antiga","year":"2013","journal-title":"G Ital Dermatol Venereol"},{"key":"B47","first-page":"407","article-title":"Persistent pruritic papulovesicles","volume":"90","author":"Mistry","year":"2014","journal-title":"Am Fam Physician"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jama.2014.17575","article-title":"Diffuse vesicular rash with intractable pruritus","volume":"313","author":"Olson","year":"2015","journal-title":"JAMA"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000347108","article-title":"Acral purpura as leading clinical manifestation of dermatitis herpetiformis: report of two adult cases with a review of the literature","volume":"227","author":"Tu","year":"2013","journal-title":"Dermatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1087-0024.2004.00840.x","article-title":"IgA autoimmune disorders: development of a passive transfer mouse model","volume":"9","author":"Zone","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"B51","first-page":"386","article-title":"Purpura in dermatitis herpetiformis","volume":"84","author":"Marks","year":"1971","journal-title":"Br J Dermatol"},{"key":"B52","article-title":"Palmar petechiae in dermatitis herpetiformis: a case report and clinical review","author":"McCleskey","year":"2002","journal-title":"Cutis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1525-1470.1994.tb00096.x","article-title":"Palmar purpura: an atypical presentation of childhood dermatitis herpetiformis","volume":"11","author":"McGovern","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S0190-9622(87)80040-3","article-title":"Purpuric papules and vesicles of the palms in dermatitis herpetiformis","volume":"16","author":"Pierce","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1468-3083.2009.03200.x","article-title":"Petechiae on the fingertips as presenting symptom of dermatitis herpetiformis Duhring","volume":"23","author":"Hofmann","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1001\/archdermatol.2011.293","article-title":"Leukocytoclastic vasculitis as the presenting feature of dermatitis herpetiformis","volume":"147","author":"Naylor","year":"2011","journal-title":"Arch Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jdcr.2017.06.033","article-title":"Dermatitis herpetiformis presenting as pseudovasculitis","volume":"3","author":"Kern","year":"2017","journal-title":"JAAD Case Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/j.1365-2133.2003.05660.x","article-title":"Dermatitis herpetiformis Duhring with palmoplantar keratosis","volume":"149","author":"Ohshima","year":"2003","journal-title":"Br J Dermatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.0736-8046.2004.21509.x","article-title":"Dermatitis herpetiformis presenting as chronic urticaria","volume":"21","author":"Powell","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-2230.2005.02009.x","article-title":"Atypical dermatitis herpetiformis: a Japanese case that presented with initial lesions mimicking prurigo pigmentosa","volume":"31","author":"Saito","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0190-9622(87)70250-3","article-title":"Familial incidence of dermatitis herpetiformis","volume":"17","author":"Meyer","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2133.1996.tb16220.x","article-title":"Incidence of familial dermatitis herpetiformis","volume":"134","author":"Reunala","year":"1996","journal-title":"Br J Dermatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/003655202753387356","article-title":"First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis","volume":"37","author":"Hervonen","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1744-313X.1996.tb00124.x","article-title":"HLA class II region genes and susceptibility to dermatitis herpetiformis: DPB1 and TAP2 associations are secondary to those of the DQ subregion","volume":"23","author":"Hall","year":"1996","journal-title":"Eur J Immunogenet."},{"key":"B65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1399-0039.1997.tb02706.x","article-title":"Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers","volume":"49","author":"Spurkland","year":"1997","journal-title":"Tissue Antigens"},{"key":"B66","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/tan.13065","article-title":"Different DRB1*03:01-DQB1*02:01 haplotypes confer different risk for celiac disease","volume":"90","author":"Alshiekh","year":"2017","journal-title":"HLA"},{"key":"B67","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000246957","article-title":"Polymorphism of the tumor necrosis factor genes in patients with dermatitis herpetiformis","volume":"189","author":"Messer","year":"1994","journal-title":"Dermatology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e0152476","DOI":"10.1371\/journal.pone.0152476","article-title":"Identification of non-HLA genes associated with celiac disease and country-specific differences in a large, international pediatric cohort","volume":"11","author":"Sharma","year":"2016","journal-title":"PLoS ONE"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.998","article-title":"Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease","volume":"43","author":"Trynka","year":"2011","journal-title":"Nat Genet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.4049\/jimmunol.169.10.5595","article-title":"HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice","volume":"169","author":"Black","year":"2002","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.23750\/abm.v89i9-S.7953","article-title":"Genetic susceptibilty and celiac disease: what role do HLA haplotypes play?","volume":"89","author":"Sciurti","year":"2018","journal-title":"Acta Biomed"},{"key":"B72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1423-0127-19-88","article-title":"HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing","volume":"19","author":"Megiorni","year":"2012","journal-title":"J Biomed Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl","year":"2018","journal-title":"Lancet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jdermsci.2003.11.004","article-title":"Dermatitis herpetiformis: close to unravelling a disease","volume":"34","author":"Karpati","year":"2004","journal-title":"J Dermatol Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2340\/00015555-2162","article-title":"Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet","volume":"95","author":"Reunala","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1172\/JCI200421055","article-title":"A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice","volume":"114","author":"Marietta","year":"2004","journal-title":"J Clin Invest"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jid.2016.11.003","article-title":"Research techniques made simple: mouse models of autoimmune blistering diseases","volume":"137","author":"Pollmann","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"562168","DOI":"10.1155\/2012\/562168","article-title":"Distinct characteristics in Japanese dermatitis herpetiformis: a review of all 91 Japanese patients over the last 35 years","volume":"2012","author":"Ohata","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jid.2015.10.057","article-title":"The HLA alleles B*0801 and DRB1*0301 are associated with dermatitis herpetiformis in a chinese population","volume":"136","author":"Sun","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1365-2133.1980.tb07250.x","article-title":"The potassium iodide patch test in the dermatitis herpetiformis in relation to treatment with a gluten-free diet and dapsone","volume":"103","author":"Haffenden","year":"1980","journal-title":"Br J Dermatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0190-9622(08)80847-X","article-title":"Can chemicals precipitate dermatitis herpetiformis?","volume":"28","author":"Snider","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/archderm.1997.03890370125031","article-title":"Dermatitis herpetiformis following gastric surgery","volume":"133","author":"Kovaleski","year":"1997","journal-title":"Arch Dermatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/j.jaad.2014.01.854","article-title":"A case of dermatitis herpetiformis after a mini-gastric bypass surgery","volume":"71","author":"Stephan","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2340\/00015555-2849","article-title":"Ex vivo culture of duodenal biopsies from patients with dermatitis herpetiformis indicates that transglutaminase 3 antibody production occurs in the gut","volume":"98","author":"Hietikko","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1507\/endocrj.44.437","article-title":"Dermatitis herpetiformis cured by hormone replacement for panhypopituitarism","volume":"44","author":"Spitzweg","year":"1997","journal-title":"Endocr J"},{"key":"B87","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0151-9638(07)89198-8","article-title":"Dermatitis herpetiformis associated with progesterone contraception","volume":"134","author":"Hassan","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"B88","first-page":"49","article-title":"Leuprolide acetate-induced dermatitis herpetiformis","volume":"75","author":"Grimwood","year":"2005","journal-title":"Cutis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jaad.2005.08.024","article-title":"Dermatitis herpetiformis associated with administration of a gonadotropin-releasing hormone analog","volume":"54","author":"Yu","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1684\/ejd.2007.0323","article-title":"Dermatitis herpetiformis in a patient receiving infliximab for ankylosing spondylitis","volume":"18","author":"Marakli","year":"2008","journal-title":"Eur J Dermatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/cup.12735","article-title":"Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma","volume":"43","author":"Mochel","year":"2016","journal-title":"J Cutan Pathol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"4625472","DOI":"10.1155\/2018\/4625472","article-title":"The central role of inflammation associated with checkpoint inhibitor treatments","volume":"2018","author":"Vajaitu","year":"2018","journal-title":"J Immunol Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jdermsci.2014.11.003","article-title":"Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis","volume":"77","author":"Antiga","year":"2015","journal-title":"J Dermatol Sci"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/j.1346-8138.2012.01663.x","article-title":"Two Japanese cases of dermatitis herpetiformis associated each with lung cancer and autoimmune pancreatitis but showing no intestinal symptom or circulating immunoglobulin A antibodies to any known antigens","volume":"39","author":"Shigeta","year":"2012","journal-title":"J Dermatol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3389\/fmicb.2017.01392","article-title":"Microbes and viruses are bugging the gut in celiac disease","volume":"8","author":"Lerner","year":"2017","journal-title":"Front Microbiol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.aah5298","article-title":"Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease","volume":"356","author":"Bouziat","year":"2017","journal-title":"Science"},{"key":"B97","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2340\/0001555573430432","article-title":"Adenovirus 12 and dermatitis herpetiformis","volume":"73","author":"Handley","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrm1014","article-title":"Transglutaminases: crosslinking enzymes with pleiotropic functions","volume":"4","author":"Lorand","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/exd.13449","article-title":"Transglutaminases in autoimmune and inherited skin diseases: the phenomena of epitope spreading and functional compensation","volume":"27","author":"Karpati","year":"2018","journal-title":"Exp Dermatol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.0022-202X.2005.23627.x","article-title":"Transglutaminase function in epidermis","volume":"124","author":"Eckert","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.jid.2017.02.982","article-title":"Transglutaminase 3 protects against photodamage","volume":"137","author":"Frezza","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1177\/039463200501800411","article-title":"The role of apoptosis in the pathogenesis of dermatitis herpetiformis","volume":"18","author":"Caproni","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1038\/jid.2009.142","article-title":"IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease","volume":"129","author":"Jaskowski","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.4049\/jimmunol.1003273","article-title":"Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology","volume":"186","author":"Zone","year":"2011","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0190-9622(83)70132-5","article-title":"Renal involvement and circulating immune complexes in dermatitis herpetiformis","volume":"9","author":"Reunala","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1468-3083.2004.01132.x","article-title":"Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis","volume":"19","author":"Preisz","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1525-1470.2011.01401.x","article-title":"Dermatitis herpetiformis presenting as digital petechiae","volume":"29","author":"Heinlin","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.jid.2016.03.039","article-title":"Circulating transglutaminase 3-immunoglobulin A immune complexes in dermatitis herpetiformis","volume":"136","author":"Gorog","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaad.2008.12.037","article-title":"Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet","volume":"61","author":"Rose","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1468-3083.2012.04586.x","article-title":"IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients","volume":"27","author":"Borroni","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"595","DOI":"10.4049\/jimmunol.1190031","article-title":"Comment on \u201cDermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology\u201d","volume":"187","author":"Antiga","year":"2011","journal-title":"J Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/jid.2014.368","article-title":"Transglutaminase 3 present in the IgA aggregates in dermatitis herpetiformis skin is enzymatically active and binds soluble fibrinogen","volume":"135","author":"Taylor","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/sj.jid.5700682","article-title":"Epidermal transglutaminase deposits in perilesional and uninvolved skin in patients with dermatitis herpetiformis","volume":"127","author":"Donaldson","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1046\/j.1365-2133.2002.05004.x","article-title":"3rd. Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis","volume":"147","author":"Smith","year":"2002","journal-title":"Br J Dermatol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5603\/FHC.a2017.0024","article-title":"Immunoexpression of IgA receptors (CD89, CD71) in dermatitis herpetiformis","volume":"55","author":"Gornowicz-Porowska","year":"2017","journal-title":"Folia Histochem Cytobiol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1468-3083.2006.02017.x","article-title":"Co-localization of IgA and TG3 on healthy skin of coeliac patients","volume":"21","author":"Cannistraci","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1111\/ijd.12350","article-title":"Skin manifestations of celiac disease: not always dermatitis herpetiformis","volume":"53","author":"Bonciolini","year":"2014","journal-title":"Int J Dermatol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1111\/bjd.15995","article-title":"Disappearance of epidermal transglutaminase and IgA deposits from the papillary dermis of patients with dermatitis herpetiformis after a long-term gluten-free diet","volume":"178","author":"Hietikko","year":"2018","journal-title":"Br J Dermatol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.jid.2018.03.1497","article-title":"Sensitivity of Transglutaminase 3 in the IgA aggregates in dermatitis herpetiformis skin to potassium iodide","volume":"138","author":"Taylor","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1038\/sj.jid.5700929","article-title":"Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten","volume":"127","author":"Hall","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/sj.jid.5700277","article-title":"Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alpha","volume":"126","author":"Hall","year":"2006","journal-title":"J Invest Dermatol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1365-2133.1993.tb00479.x","article-title":"The role of cytokines in the generation of skin lesions in dermatitis herpetiformis","volume":"129","author":"Graeber","year":"1993","journal-title":"Br J Dermatol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/DAD.0000000000000915","article-title":"Expression of elafin in dermatitis herpetiformis","volume":"40","author":"Ollague","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.1038\/s41598-018-28070-0","article-title":"Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction","volume":"8","author":"Russo","year":"2018","journal-title":"Sci Rep"},{"key":"B126","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0190-9622(92)70172-C","article-title":"The site of blister formation in dermatitis herpetiformis is within the lamina lucida","volume":"27","author":"Smith","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/1346-8138.12630","article-title":"A case of dermatitis herpetiformis with blister formation between laminin-332 and type 7 collagen","volume":"41","author":"Suzuki","year":"2014","journal-title":"J Dermatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/1523-1747.ep12317093","article-title":"Enhanced expression of interstitial collagenase, stromelysin-1, and urokinase plasminogen activator in lesions of dermatitis herpetiformis","volume":"105","author":"Airola","year":"1995","journal-title":"J Invest Dermatol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/jdv.12913","article-title":"High prevalence of cryofibrinogenaemia in dermatitis herpetiformis","volume":"30","author":"Bognar","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jdermsci.2016.07.005","article-title":"Decreased fibrinolytic potential and morphological changes of fibrin structure in dermatitis herpetiformis","volume":"84","author":"Gorog","year":"2016","journal-title":"J Dermatol Sci"},{"key":"B131","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2249.2011.04391.x","article-title":"Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases","volume":"165","author":"Marzano","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"870428","DOI":"10.1155\/2015\/870428","article-title":"Tissue factor in dermatitis herpetiformis and bullous pemphigoid: link between immune and coagulation system in subepidermal autoimmune bullous diseases","volume":"2015","author":"Zebrowska","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B133","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1046\/j.1365-2133.1998.02068.x","article-title":"Th2-like cytokine activity in dermatitis herpetiformis","volume":"138","author":"Caproni","year":"1998","journal-title":"Br J Dermatol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2133.1981.tb01202.x","article-title":"Inflammatory cells, IgA, C3, fibrin and fibronectin in skin lesions in dermatitis herpetiformis","volume":"105","author":"Reitamo","year":"1981","journal-title":"Br J Dermatol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000058005","article-title":"Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-L-like cytokines in Dermatitis herpetiformis","volume":"128","author":"Caproni","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2340\/00015555-2604","article-title":"Increased serum levels of Th2-type cytokines and eotaxin in fibrillar-type dermatitis herpetiformis","volume":"97","author":"Makino","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B137","first-page":"31","article-title":"Expression of selected neuropeptides in pathogenesis of bullous pemphigoid and dermatitis herpetiformis","volume":"63","author":"Cynkier","year":"2012","journal-title":"Pol J Pathol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/ijd.12666","article-title":"The frequencies of haplotypes defined by three polymorphisms of the IL-31 gene:\u22121066,\u22122057, and IVS2+12 in Polish patients with atopic dermatitis","volume":"54","author":"Sokolowska-Wojdylo","year":"2015","journal-title":"Int J Dermatol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1182\/blood-2008-09-179416","article-title":"Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders","volume":"113","author":"Ishii","year":"2009","journal-title":"Blood"},{"key":"B140","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2340\/00015555-1958","article-title":"Il-31 does not correlate to pruritus related to early stage cutaneous T-cell lymphomas but is involved in pathogenesis of the disease","volume":"95","author":"Malek","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11882-014-0423-y","article-title":"Interleukin-31: a novel diagnostic marker of allergic diseases","volume":"14","author":"Rabenhorst","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jaci.2007.07.065","article-title":"A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema","volume":"120","author":"Schulz","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jaci.2012.11.008","article-title":"Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients","volume":"132","author":"Hartmann","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/ni1084","article-title":"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice","volume":"5","author":"Dillon","year":"2004","journal-title":"Nat Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2340\/00015555-2474","article-title":"Interleukin-31 polymorphisms and serum IL-31 level in patients with mastocytosis: correlation with clinical presen-tation and pruritus","volume":"97","author":"Lange","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2340\/00015555-1191","article-title":"IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis","volume":"92","author":"Nobbe","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jid.2017.12.029","article-title":"The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch","volume":"138","author":"Nattkemper","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2340\/00015555-2417","article-title":"Cutaneous T-cell lymphoma and pruritus: the expression of IL-31 and its receptors in the skin","volume":"96","author":"Nattkemper","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jaad.2014.08.004","article-title":"Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis","volume":"71","author":"Ko","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ejcb.2011.07.006","article-title":"Signaling by IL-31 and functional consequences","volume":"91","author":"Cornelissen","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fmed.2018.00201","article-title":"The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease","volume":"5","author":"Amber","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B152","doi-asserted-by":"publisher","first-page":"5965492","DOI":"10.1155\/2017\/5965492","article-title":"The role of intereukin-31 in pathogenesis of itch and its intensity in a course of bullous pemphigoid and dermatitis herpetiformis","volume":"2017","author":"Kulczycka-Siennicka","year":"2017","journal-title":"Biomed Res Int"},{"key":"B153","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jdermsci.2017.04.008","article-title":"Serum levels and tissue expression of interleukin-31 in dermatitis herpetiformis and bullous pemphigoid","volume":"87","author":"Bonciani","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1606490","article-title":"Anti-interleukin-31 receptor A antibody for atopic dermatitis","volume":"376","author":"Ruzicka","year":"2017","journal-title":"N Engl J Med"},{"key":"B155","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1741-7015-10-13","article-title":"Spectrum of gluten-related disorders: consensus on new nomenclature and classification","volume":"10","author":"Sapone","year":"2012","journal-title":"BMC Med"},{"key":"B156","first-page":"4","article-title":"Gluten intolerance and skin diseases","volume":"16","author":"Humbert","year":"2006","journal-title":"Eur J Dermatol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"E800","DOI":"10.3390\/nu10070800","article-title":"Cutaneous and mucosal manifestations associated with celiac disease","volume":"10","author":"Rodrigo","year":"2018","journal-title":"Nutrients"},{"key":"B158","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/0019-5154.198031","article-title":"Psoriasis and risk of celiac disease: a systematic review and meta-analysis","volume":"62","author":"Ungprasert","year":"2017","journal-title":"Indian J Dermatol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jaad.2014.03.017","article-title":"Diet and psoriasis, part II: celiac disease and role of a gluten-free diet","volume":"71","author":"Bhatia","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/pde.13542","article-title":"When your patient's parent asks: \u201cMy child's alopecia areata is not getting better","volume":"35","author":"Kaplan","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"7798","DOI":"10.3390\/nu7095368","article-title":"Cutaneous manifestations of non-celiac gluten sensitivity: clinical histological and immunopathological features","volume":"7","author":"Bonciolini","year":"2015","journal-title":"Nutrients"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.12.013","article-title":"Classification of cutaneous manifestations in patients with non-celiac gluten sensitivity (NCGS) and wheat allergy (WA)","author":"Faina","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.3390\/nu7064966","article-title":"Diagnosis of non-celiac gluten sensitivity (NCGS): the salerno experts' criteria","volume":"7","author":"Catassi","year":"2015","journal-title":"Nutrients"},{"key":"B164","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00000372-200208000-00003","article-title":"Characterization of a subgroup of patients with dermatitis herpetiformis with nonclassical histologic features","volume":"24","author":"Warren","year":"2002","journal-title":"Am J Dermatopathol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/ddg.12746","article-title":"Acantholytic variant of Duhring's disease","volume":"14","author":"Ziemer","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"B166","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2340\/00015555-2379","article-title":"Granular C3 dermatosis","volume":"96","author":"Hashimoto","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1365-4632.2007.03214.x","article-title":"3rd. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience","volume":"46","author":"Alonso-Llamazares","year":"2007","journal-title":"Int J Dermatol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1309\/AJCPXIVSR6OZK1HU","article-title":"Utility of direct immunofluorescence testing for IgA in patients with high and low clinical suspicion for dermatitis herpetiformis","volume":"144","author":"Bresler","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0190-9622(00)70284-2","article-title":"A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescent findings","volume":"43","author":"Beutner","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1365-4632.2011.04909.x","article-title":"Negative direct immunofluorescence and nonspecific histology do not exclude the diagnosis of dermatitis herpetiformis Duhring","volume":"52","author":"Huber","year":"2013","journal-title":"Int J Dermatol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/CCID.S69127","article-title":"The diagnosis and treatment of dermatitis herpetiformis","volume":"8","author":"Antiga","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.dld.2016.03.003","article-title":"Serum transglutaminase 3 antibodies correlate with age at celiac disease diagnosis","volume":"48","author":"Salmi","year":"2016","journal-title":"Dig Liver Dis"},{"key":"B173","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.cca.2012.10.051","article-title":"Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease\u2013dermatitis herpetiformis","volume":"415","author":"Lytton","year":"2013","journal-title":"Clin Chim Acta"},{"key":"B174","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jaad.2011.02.025","article-title":"Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides","volume":"66","author":"Kasperkiewicz","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/jgh.12514","article-title":"Issues associated with the emergence of coeliac disease in the Asia-Pacific region: a working party report of the World Gastroenterology Organization and the Asian Pacific Association of Gastroenterology","volume":"29","author":"Makharia","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/ijd.13725","article-title":"Trichoscopy - a useful tool in the preliminary differential diagnosis of autoimmune bullous diseases","volume":"56","author":"Sar-Pomian","year":"2017","journal-title":"Int J Dermatol"},{"key":"B177","first-page":"843","article-title":"Dermatitis herpetiformis: relevance of the physical examination to diagnosis suspicion","volume":"58","author":"Criado","year":"2012","journal-title":"Can Fam Physician"},{"key":"B178","doi-asserted-by":"publisher","first-page":"756138","DOI":"10.1155\/2014\/756138","article-title":"A metabolomic perspective on coeliac disease","volume":"2014","author":"Calabro","year":"2014","journal-title":"Autoimmune Dis"},{"key":"B179","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.3389\/fmicb.2018.02597","article-title":"Cross-talk between gluten, intestinal microbiota and intestinal mucosa in celiac disease: recent advances and basis of autoimmunity","volume":"9","author":"Chander","year":"2018","journal-title":"Front Microbiol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1097\/MIB.0b013e31828029a9","article-title":"The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease","volume":"19","author":"Wacklin","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"B181","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1001\/archdermatol.2011.221","article-title":"Gluten-free diet in patients with dermatitis herpetiformis: not only a matter of skin","volume":"147","author":"Antiga","year":"2011","journal-title":"Arch Dermatol."},{"key":"B182","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D32622H9K7","article-title":"Dermatitis herpetiformis and gluten-free diet","volume":"11","author":"Turchin","year":"2005","journal-title":"Dermatol Online J"},{"key":"B183","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejim.2018.11.012.","article-title":"Management of celiac disease in daily clinical practice","volume":"61","author":"Elli","year":"2018","journal-title":"Eur J Intern Med"},{"key":"B184","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1590\/abd1806-4841.20142966","article-title":"Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment","volume":"89","author":"Clarindo","year":"2014","journal-title":"An Bras Dermatol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2340\/00015555-2184","article-title":"Dermatitis herpetiformis refractory to gluten-free dietary treatment","volume":"96","author":"Hervonen","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fmed.2014.00006","article-title":"Current and emerging therapy for celiac disease","volume":"1","author":"Makharia","year":"2014","journal-title":"Front Med (Lausanne)"},{"key":"B187","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1073\/pnas.1007773107","article-title":"Effective shutdown in the expression of celiac disease-related wheat gliadin T-cell epitopes by RNA interference","volume":"107","author":"Gil-Humanes","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B188","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5009\/gnl14288","article-title":"Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms","volume":"9","author":"Freeman","year":"2015","journal-title":"Gut Liver"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial","volume":"148","author":"Leffler","year":"2015","journal-title":"Gastroenterology"},{"key":"B190","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ebiom.2017.11.018","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in celiac disease: safety, pharmacokinetics, and effects on intestinal histology and plasma cytokines with escalating dose regimens of nexvax2 in a randomized, double-blind, placebo-controlled phase 1 study","volume":"26","author":"Daveson","year":"2017","journal-title":"EBioMedicine"},{"key":"B191","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fped.2018.00350","article-title":"Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies","volume":"6","author":"Tye-Din","year":"2018","journal-title":"Front Pediatr"},{"key":"B192","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1177\/1203475416651053","article-title":"Topical dapsone 5% gel as an effective therapy in dermatitis herpetiformis","volume":"20","author":"Burbidge","year":"2016","journal-title":"J Cutan Med Surg"},{"key":"B193","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3315\/jdcr.2012.1124","article-title":"Letter to the editor: Application of dapsone 5% gel in a patient with dermatitis herpetiformis","volume":"6","author":"Handler","year":"2012","journal-title":"J Dermatol Case Rep"},{"key":"B194","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1111\/ijd.13542","article-title":"Dapsone and sulfasalazine combination therapy in dermatitis herpetiformis","volume":"56","author":"Bevans","year":"2017","journal-title":"Int J Dermatol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1111\/ijd.13641","article-title":"Dermatitis herpetiformis (Duhring's disease): a therapeutic challenge","volume":"56","author":"Abdelmaksoud","year":"2017","journal-title":"Int J Dermatol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/jamadermatol.2016.4676","article-title":"Rituximab treatment for recalcitrant dermatitis herpetiformis","volume":"153","author":"Albers","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMoa1404172","article-title":"Randomized feeding intervention in infants at high risk for celiac disease","volume":"371","author":"Vriezinga","year":"2014","journal-title":"N Engl J Med"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa1400697","article-title":"Introduction of gluten, HLA status, and the risk of celiac disease in children","volume":"371","author":"Lionetti","year":"2014","journal-title":"N Engl J Med"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3389\/fmicb.2018.01835","article-title":"The human gut microbiome - a potential controller of wellness and disease","volume":"9","author":"Kho","year":"2018","journal-title":"Front Microbiol"},{"key":"B200","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.autrev.2015.01.009","article-title":"Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease","volume":"14","author":"Lerner","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B201","doi-asserted-by":"publisher","first-page":"8980534","DOI":"10.1155\/2017\/8980534","article-title":"Correlation between IL36alpha and IL17 and activity of the disease in selected autoimmune blistering diseases","volume":"2017","author":"Zebrowska","year":"2017","journal-title":"Mediators Inflamm"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01290\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T06:19:38Z","timestamp":1694931578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01290\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":201,"alternative-id":["10.3389\/fimmu.2019.01290"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01290","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"article-number":"1290"}}